Biotech Patents

Analysis, Insights and Strategies for New Challenges in Biotech Patent Practice

Monday, September 15, 2008

About

This is a crucial time for biotech patents, and it is essential that you be ready to deal with the inevitable adjustments to the practice. As such, American Conference Institute has specifically designed its annual publication from the 10th Advanced Forum on Biotech Patents to provide you with a sophisticated and comprehensive understanding of the issues you face today. In addition, our esteemed faculty guide you to the most effective practices you need to ensure protection of your biotech discovery.

Contents & Contributors

About

This is a crucial time for biotech patents, and it is essential that you be ready to deal with the inevitable adjustments to the practice. As such, American Conference Institute has specifically designed its annual publication from the 10th Advanced Forum on Biotech Patents to provide you with a sophisticated and comprehensive understanding of the issues you face today. In addition, our esteemed faculty guide you to the most effective practices you need to ensure protection of your biotech discovery.

Contents & Contributors

KEY BIOTECH CASES TO WATCH AND HOW THEY MAY IMPACT YOUR PRACTICE
Harold C. Wegner, Foley & Lardner LLC (Washington, D.C.

MAXIMIZING PRACTICE IN THE USPTO – 1600
Bill McCarthy, M.Sc., 454 Life Sciences, a subsidiary of Roche Diagnostics (Branford, CT)
Denise Kettelberger, Ph.D., Merchant & Gould P.C. (Minneapolis, MN)

NAVIGATING THE BOARD OF PATENT APPEALS AND INTERFERENCES IN LIGHT OF THE KSR DECISION
Daniel J. Pereira, Ph.D., Oblon, Spivak, McClelland, Maier & Neustadt, P.C. (Alexandria, VA)
James F. Ewing, Ph.D., Foley & Lardner LLP

USPTO RULEMAKINGS: FINAL AND PROPOSED
Michele A. Cimbala, Sterne, Kessler, Goldstein & Fox P.L.L.C (Washington, D.C.)

BIOTECH LIFE ON THE PATENT TIGHTROPE
Stephen R. Albainy-Jenei, Frost Brown Todd LLC (Cincinnati, OH)

THEY ARE COMING: PREPARING YOUR PRACTICE FOR THE INEVITABLE INSURGENCE OF FOLLOW-ON BIOLOGICS AND PREDICTION THE FUTURE OF THE BIOTECH INDUSTRY
Dr. Wolfgang Rehmann, Taylor Wessing LLP (Munich, Germany)

THE INTERNATIONAL PERSPECTIVE: PATENT PRACTICES IN THE EU – LITIGATION AND STRATEGY
Nigel Stoate, Taylor Wessing LLP (London, England)

DIFFERENCES BETWEEN THE EUROPEAN AND THE U.S. PATENT SYSTEMS
Anthony C. Tridico, Ph.D., Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (Washington, D.C.)

PRACTICING BIOTECHNOLOGY ARTS: CLAIM DRAFTING STRATEGIES
Cynthia M. Soroos, Lahive & Cockfield, LLP (Boston, MA)
David Rucando, PhD, Alseres Pharmaceuticals, Inc. (Hopkinton, MA)

EX PARTE KUBIN: A CASE STUDY
Janis K. Fraser, Ph.D., Fish & Richardson P.C. (Boston, MA)
Kevin E. Noonan, Ph.D., McDonnell Boehnen Hulbert & Berghoff LLP (Chicago, IL)

STRATEGIES TO PREVENT ALLEGATIONS OF INEQUITABLE CONDUCT
Hollie L. Baker, WilmerHale (Boston, MA)
Mark I. Bowditch, Sandoz, Inc. (Princeton, NJ)



DOCUMENT TYPES: PPTX PPT PDF PRESENTATIONS AVAILABLE: 15

7:30
Registration and Continental Breakfast
8:30
Co-Chairs' Opening Remarks
Brian Coggio, Esq.
Senior Principal
Fish & Richardson‚ P.C.
Dr. Immac J. Thampoe
Managing IP Counsel, Biologics
Merck & Co., Inc.
9:00
Key Biotech Cases to Watch and How They May Impact Your Practice
Ms Harold Wegner
Partner
Foley & Lardner LLC
1 file
Wegner.Harold
130.2 KB 33 pages Presentation
PPTX - Wegner.Harold
10:15
Morning Coffee Break
10:30
The Industry Speaks: Maximizing Your Relationship with the PTO
Mr. Bill McCarthy
Patent Agent
454 Life Sciences‚ a subsidiary of Roche Doagnostic
1 file
McCarthy.W.1a
253.9 KB 20 pages Presentation
PDF - McCarthy.W.1a
Ms Denise Kettelberger, Ph.D.
Attorney
Merchant & Gould PC
1 file
McCarthy.Kettelberger.Revised
263.5 KB 33 pages Presentation
PPT - McCarthy.Kettelberger.Revised
12:00
Networking Luncheon for Speakers & Delegates
13:15
Navigating the Board of Patent Appeals and Interferences in Light of the KSR decision
Mr. Daniel Pereira, Ph.D.
Partner
Oblon‚ Spivak‚ McClelland‚ Maier & Neustadt‚ P.C.
Mr. James Ewing
Senior Counsel
Foley & Lardner LLC
1 file
Ewing.Pereira
1 MB 56 pages Presentation
PDF - Ewing.Pereira
14:30
Afternoon Refreshment Break
14:45
Life on the Patent Tightrope: Updates on the Proposed Rules and Patent Reform
Dr. Michele Cimbala
Director‚ Intellectual Property
Sterne‚ Kessler‚ Goldstein & Fox P.L.L.C.
1 file
Cimbala.Michele
2 MB 58 pages Presentation
PPT - Cimbala.Michele
Mr. Stephen Albainy-Jenei
Member
Frost‚ Brown‚ Todd‚ LLC
1 file
Albainy-Jenei.S.1a
311 KB 32 pages Presentation
PPT - Albainy-Jenei.S.1a
16:00
They Are Coming: Preparing Your Practice for the Inevitable Insurgence of Follow-On Biologics and Predicting the Future of the Biotech Industry
Ms. Barbara Fiacco
Partner
Foley Hoag LLP
1 file
Fiacco.Barbara
3.6 MB 34 pages Presentation
PPT - Fiacco.Barbara
16:00
The Regulatory Pathway to Europe
Dr. Wolfgang Rehmann
Partner
Taylor Wessing LLP
1 file
Rehmann.W.1a
317.5 KB 18 pages Presentation
PPT - Rehmann.W.1a
17:30
Conference Adjourns
7:30
Continental Breakfast
8:30
Co-Chairs' Opening Remarks
9:00
The International Perspective: Changing Patent Practices in the EU and India
Mr. Sandeep Rathod
Head of Corporate and Formulations IP
Matrix Laboratories Limited
1 file
Rathod.S.1a
154.9 KB 17 pages Presentation
PDF - Rathod.S.1a
Mr. Nigel Stoate
Partner
Taylor Wessing LLP
1 file
Stoate.Nigel
460 KB 24 pages Presentation
PPT - Stoate.Nigel
Dr. Anthony C. Tridico
Partner
Finnegan‚ Henderson‚ Farabow‚ Garrett & Dunner‚ LLP
1 file
Tridico.Anthony
1.3 MB 21 pages Presentation
PPT - Tridico.Anthony
10:25
Morning Coffee Break
10:40
Practicing Biotechnology Arts: Claim Drafting Strategies
Mr. David Rucando
Director‚ Intellectual Property
Alseres Pharmaceuticals‚ Inc.
1 file
Rucando.Soroos.Revised
579 KB 77 pages Presentation
PPT - Rucando.Soroos.Revised
Ms Cynthia Soroos
Of Counsel
Lahive & Cockfield‚ LLP
11:45
Ex Parte Kubin: A Case Study
-Mr. Kevin E. Noonan‚ Ph.D.
Partner
McDonnell Boehnen Hulbert & Berghoff LLP
Ms Janis Fraser, PhD.
Principal
Fish and Richardson&sbquo P.C.
1 file
Noonan.Fraser.Revised
401 KB 65 pages Presentation
PPT - Noonan.Fraser.Revised
13:00
Networking Luncheon
14:15
Strategies and Applications to Implement During All Stages of the Biotech Patent Prosecution Process to Prevent Allegations of Inequitable Conduct
Ms. Hollie L. Baker
Partner
Wilmer Hale LLP
Mark Bowditch, Esq.
Executive Director, Head, US Product Support
Sandoz‚ Inc.
1 file
Bowditch.Baker.Revised
613.5 KB 38 pages Presentation
PPT - Bowditch.Baker.Revised
15:30
Different But the Same: The Unique Nature of Prosecuting Antibody Therapeutics Applications Under the Standard Patent Prosecution Process
Ms Maria Zacharakis, Ph.D.
Partner
Lahive & Cockfield, LLP
1 file
Zacharakis.Maria
700 KB 34 pages Presentation
PPT - Zacharakis.Maria
16:30
Conference Ends